Shannan Ponton joins our March for a cure
17 January 2018
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
His melanoma story began on a beach in Bali when his wife spotted a suspicious looking mole on the back of his thigh. She booked him in for a skin check immediately on his return to Sydney – it was melanoma.
Despite undergoing two rounds of surgery and now sporting a 20cm scar, his melanoma hadn’t spread. He was so rattled by his melanoma diagnosis that he immediately called an ‘intervention’ with his mates, inviting 15 of them around to his house for a BBQ.
“I said boys, we all lead a similar lifestyle. I’ve just been diagnosed with melanoma. I want all of you to go and get a skin check,” Shannan recalls.
All 15 mates at Shannan’s ‘intervention’ that afternoon booked themselves in for skins checks - two were subsequently diagnosed with melanoma.
“If it wasn’t for that intervention and that feeling in my gut to go beyond trying to just help, and actually making a difference, those two guys could not be here now,” Shannan added.
Shannan’s story is the first to be featured in a series of emotive videos launched today by Melanoma Institute Australia, showing the impact of melanoma on everyday Australians. Stories to follow will include a young family devastated by melanoma; and a pregnant woman faced with the impossible choice of delivering her baby early or delaying melanoma treatment.
Join us at the 2nd Melanoma Patients Australia webinar 'Psychological Health & Wellbeing'.
You're invited to be a C2S charity superstar, and together we can run over melanoma!
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.